As of December 2024, Inhibitor Therapeutics has a market cap of $11.70M. This makes Inhibitor Therapeutics the world's 5174th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $12.90M | -18.48% |
2023 | $15.83M | -7.07% |
2022 | $17.03M | -34.00% |
2021 | $25.80M | 328.57% |
2020 | $6.02M | -37.50% |
2019 | $9.63M | -6.67% |
2018 | $10.32M | -76.10% |
2017 | $43.18M | -35.64% |
2016 | $67.09M | 200.00% |
2015 | $22.36M | 4.00% |
2014 | $21.50M | 52.44% |
2013 | $14.11M | - |